Jpmorgan Chase & CO Century Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.51 Trillion
  • Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,593 shares of IPSC stock, worth $748. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,593
Previous 1,593 -0.0%
Holding current value
$748
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$0.47 - $0.66 $31,911 - $44,812
-67,897 Reduced 97.71%
1,593 $0
Q1 2025

May 12, 2025
SELL
$0.48 - $1.11 $44,975 - $104,005
-93,699 Reduced 57.42%
69,490 $33,000
Q4 2024

Feb 12, 2025
BUY
$1.0 - $1.72 $91,468 - $157,324
91,468 Added 127.53%
163,189 $164,000
Q3 2024

Dec 26, 2024
BUY
$1.44 - $3.29 $74,396 - $169,974
51,664 Added 257.59%
71,721 $122,000
Q3 2024

Nov 08, 2024
BUY
$1.44 - $3.29 $74,396 - $169,974
51,664 Added 257.59%
71,721 $122,000
Q2 2024

Dec 26, 2024
SELL
$2.46 - $4.05 $127,093 - $209,239
-51,664 Reduced 72.03%
20,057 $51,000
Q2 2024

Aug 12, 2024
SELL
$2.46 - $4.05 $13,832 - $22,773
-5,623 Reduced 21.9%
20,057 $51,000
Q1 2024

Dec 26, 2024
SELL
$3.19 - $5.32 $146,870 - $244,938
-46,041 Reduced 64.19%
25,680 $107,000
Q1 2024

May 10, 2024
BUY
$3.19 - $5.32 $33,488 - $55,849
10,498 Added 69.15%
25,680 $107,000
Q4 2023

Dec 26, 2024
SELL
$1.28 - $3.32 $72,369 - $187,709
-56,539 Reduced 78.83%
15,182 $50,000
Q4 2023

Feb 12, 2024
SELL
$1.28 - $3.32 $14,516 - $37,652
-11,341 Reduced 42.76%
15,182 $50,000
Q3 2023

Nov 14, 2023
BUY
$2.0 - $3.23 $11,614 - $18,756
5,807 Added 28.03%
26,523 $53,000
Q2 2023

Aug 11, 2023
SELL
$2.91 - $3.53 $131,054 - $158,977
-45,036 Reduced 68.49%
20,716 $65,000
Q1 2023

May 18, 2023
BUY
$3.4 - $5.11 $52,451 - $78,831
15,427 Added 30.65%
65,752 $228,000
Q1 2023

May 11, 2023
SELL
$3.4 - $5.11 $51,462 - $77,344
-15,136 Reduced 23.12%
50,325 $174,000
Q4 2022

Feb 13, 2023
BUY
$4.84 - $11.58 $11,422 - $27,328
2,360 Added 3.74%
65,461 $335,000
Q3 2022

Nov 14, 2022
SELL
$8.57 - $13.1 $19,325 - $29,540
-2,255 Reduced 3.45%
63,101 $624,000
Q2 2022

Aug 11, 2022
BUY
$7.96 - $12.43 $49,646 - $77,525
6,237 Added 10.55%
65,356 $548,000
Q1 2022

May 11, 2022
SELL
$11.62 - $15.92 $950,911 - $1.3 Million
-81,834 Reduced 58.06%
59,119 $744,000
Q4 2021

Feb 10, 2022
BUY
$13.93 - $23.62 $1.08 Million - $1.83 Million
77,529 Added 122.24%
140,953 $2.24 Million
Q3 2021

Nov 12, 2021
BUY
$20.8 - $31.93 $1.32 Million - $2.03 Million
63,424 New
63,424 $1.6 Million

Others Institutions Holding IPSC

# of Institutions
56
Shares Held
22.5M
Call Options Held
0
Put Options Held
0
View Full List

About Century Therapeutics, Inc.

IPSC Quotes by TradingView
  • Ticker IPSC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,881,800
  • Market Cap $27.7M
  • Description
  • Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...
More about IPSC
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email